As shown in Fig. 6a, b, inhibiting ACSL4 obviously downregulated the high expression of TGF-β, p-Smad3 as well as p-Smad2 in both UUO and FA-treated kidneys. This evidence concerns the gene SMAD3 and Friedreich ataxia.